Postoperative Nausea and Vomiting
📧 Sign up to get email alerts when something new happens for Postoperative Nausea and Vomiting.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-27Clinical Trial Update: Adding Aprepitant to a Multimodal Strategy for the Prevention of Postoperative Nausea and Vomiting in High-risk Outpatient Surgical Patients [Phase 3]
Phase 3 trial evaluating adding aprepitant to multimodal prophylaxis for postoperative nausea and vomiting in high-risk outpatient surgical …
-
CLINICAL_TRIALS trial_result · 2026-08-14Clinical Trial Results: Prevention of Post-Operative Nausea and Vomiting With Propofol Infusion [Phase 2]
Phase 2 trial evaluating propofol infusion for prevention of postoperative nausea and vomiting has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-07-29Clinical Trial Results: The Effects of IV vs Oral Dexamethasone on Postoperative Nausea, Vomiting, and Pain [Phase 4]
Phase 4 clinical trial comparing intravenous versus oral dexamethasone for postoperative nausea, vomiting, and pain; results completed and p…
-
CLINICAL_TRIALS trial_result · 2026-07-16Clinical Trial Results: The Impact of Preoperative Olanzapine on Quality of Recovery After Discharge From Ambulatory Surgery [Phase 2]
Phase 2 trial evaluating whether preoperative olanzapine improves quality of recovery after discharge in ambulatory surgery for patients wit…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: The Effect of Paedfusor TCI, Eleveld TCI, and Sevoflurane Anesthesia on Postoperative Awakening Agitation in Pediatric Patients [NA]
A clinical trial evaluating whether Paedfusor TCI, Eleveld TCI, and Sevoflurane anesthesia influence postoperative awakening agitation in pe…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2026-04-15FDA Approved: ONDANSETRON HYDROCHLORIDE — Supplemental Application (Onesource Specialty Pharma Limited)
The FDA approved a supplemental application for ondansetron hydrochloride, a generic antiemetic, with Onesource Specialty Pharma Limited as …
-
FDA approval · 2026-04-15FDA Approved: ONDANSETRON HYDROCHLORIDE — Supplemental Application (Onesource Specialty Pharma Limited)
The FDA approved a supplemental application for ondansetron hydrochloride from Onesource Specialty Pharma Limited under ANDA078257.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Electroacupuncture Plus 5-HT3 Receptor Inhibitor for PONV Prevention in High-Risk Patients Undergoing Thoracoscopic Lung Cancer Surgery [NA]
A clinical trial is recruiting to evaluate electroacupuncture plus a 5-HT3 receptor inhibitor for preventing postoperative nausea and vomiti…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: PONV Prevention Via Percutaneous Nerve Electrical Stimulation on PC6 [Phase 2]
Phase 2 clinical trial update on preventing postoperative nausea and vomiting using percutaneous nerve electrical stimulation at PC6; the st…
-
FDA approval · 2026-04-08FDA Approved: ONDANSETRON — Supplemental Application (West-Ward Pharmaceuticals Corp)
FDA approved a supplemental application for ondansetron (generic) from West-Ward Pharmaceuticals Corp.
-
FDA approval · 2026-04-08FDA Approved: ONDANSETRON — Supplemental Application (West-Ward Pharmaceuticals Corp)
The FDA approved a supplemental application for ondansetron filed by West-Ward Pharmaceuticals Corp. This action updates the product’s regul…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Effectiveness of Unilateral Transversus Abdominis Plane (TAP) Block vs Bilateral TAP Block in Patients Undergoing Laparoscopic Cholecystectomy. [NA]
Clinical trial update indicates enrollment by invitation for a study comparing unilateral versus bilateral transversus abdominis plane (TAP)…
-
FDA approval · 2026-04-03FDA Approved: ONDANSETRON — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for Ondansetron submitted by PAI Holdings, LLC dba PAI Pharma (ANDA078127). This action confirms reg…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Phase I PK and Safety Study of Ondansetron Inhalation Powder [Phase 1]
Phase I PK and safety study of ondansetron inhalation powder for postoperative nausea and vomiting has completed.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Effects of Local Ketamine in Orthognathic Procedures [NA]
A clinical trial assessing the analgesic effects of locally administered ketamine in orthognathic surgery, currently active but not recruiti…
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Dexamethasone vs Ondansetron After Cesarean Delivery [Phase 4]
A Phase 4 trial comparing dexamethasone to ondansetron for postoperative nausea and vomiting after cesarean delivery has completed, with res…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Sugammadex and Menstrual Cycle in Postoperative Nausea and Vomiting
A clinical trial is evaluating whether sugammadex affects the menstrual cycle in patients with postoperative nausea and vomiting; the study …
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Adding Aprepitant to a Multimodal Strategy for the Prevention of Postoperative Nausea and Vomiting in High-risk Outpatient Surgical Patients [Phase 3]
A Phase 3 clinical trial is recruiting to evaluate adding the antiemetic aprepitant to a multimodal strategy for preventing postoperative na…
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: Acupuncture for Prevention of Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy [NA]
A completed clinical trial evaluating acupuncture to prevent postoperative nausea and vomiting after laparoscopic cholecystectomy.
-
FDA approval · 2026-03-02FDA Approved: ONDANSETRON HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for ondansetron hydrochloride from Aurobindo Pharma Limited, confirming labeling for this generic an…
-
CLINICAL_TRIALS other · 2026-03-02Clinical Trial Update: Carbohydrate Fluids and Post Operative Nausea and Vomiting [NA]
This clinical trial update indicates that a study evaluating carbohydrate fluids for postoperative nausea and vomiting is not yet recruiting…
-
FDA approval · 2026-02-25FDA Approved: ONDANSETRON — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approves a supplemental application for a generic ondansetron hydrochloride product from Dr. Reddy's Laboratories Limited.
-
CLINICAL_TRIALS trial_result · 2026-02-23Clinical Trial Update: Comparison of Dexmedetomidine and Dexamethasone for the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Cholecystectomy [Phase 3]
A Phase 3 trial comparing dexmedetomidine and dexamethasone for prevention of postoperative nausea and vomiting in patients undergoing lapar…
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: Dexamethasone for Prevention of Postoperative Vomiting After Laparoscopic Gynecologic Surgery [NA]
This completed clinical trial evaluated dexamethasone for the prevention of postoperative nausea and vomiting after laparoscopic gynecologic…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Efficacy of Non-weight Based, Low Dose Dex-Dex Adjuncts in Prolonging Peripheral Nerve Blocks [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating non-weight-based, low-dose Dex-Dex adjuncts to prolong peripheral nerve blocks for postoperative pain …